home / stock / corv / corv news

CORV News and Press, Correvio Pharma Corp. From 12/10/19

Stock Information
Company Name: Correvio Pharma Corp.
Stock Symbol: CORV
Market: NASDAQ
Website: correvio.com
Menu
CORV CORV Quote CORV Short CORV News CORV Articles CORV Message Board
Get CORV Alerts

News, Short Squeeze, Breakout and More Instantly...
CORV - Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess(TM) For Recent Onset Atrial Fibrillation

NASDAQ: CORV   TSX: CORV VANCOUVER , Dec. 10, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that NASDAQ and the Toronto Stock Exchange (TSX) have halted trad...
CORV - BLUE, PCG among premarket gainers

Synthorx (NASDAQ: THOR ) +169%  on being acquired by Sanofi. More news on: Synthorx, Inc., XBiotech Inc., ArQule, Inc., Stocks on the move, Read more ...

CORV - TRNX, YEXT, BIG and CGIX among midday movers

Gainers:  Genesco (NYSE: GCO )  +33% . More news on: Genesco Inc., Wellesley Bancorp, Inc., Big Lots, Inc., Stocks on the move, Read more ...

CORV - YEXT, ZM among premarket losers

Taronis Technologies (NASDAQ: TRNX ) -30% . More news on: Taronis Technologies, Inc., Correvio Pharma Corp., Yext, Inc., Stocks on the move, Read more ...

CORV - Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference

NASDAQ: CORV   TSX: CORV VANCOUVER , Nov. 25, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that Mark H.N. Corrigan , MD, Chief Executive Officer of Correvi...

CORV - Correvio Announces Presentation of New Brinavess(TM) Spectrum Data at the American Heart Association 2019 Annual Meeting

Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual Meeting Canada NewsWire VANCOUVER, Nov. 18, 2019 NASDAQ: CORV   TSX: CORV Post Hoc Analysis of Subset of Patients Treated in the Emergency Depa...

CORV - Correvio Pharma's (CORV) CEO Mark Corrigan on Q3 2019 Results - Earnings Call Transcript

Correvio Pharma Corp. (CORV) Q3 2019 Earnings Conference Call November 14, 2019 08:30 AM ET Company Participants Brendan Payne – Associate Director-Investor Relations and Business Development Mark Corrigan – Chief Executive Officer Justin Renz – President and...
CORV - Correvio Pharma EPS misses by $0.06, misses on revenue

Correvio Pharma (NASDAQ: CORV ): Q3 GAAP EPS of -$0.23 misses by $0.06 . More news on: Correvio Pharma Corp., Earnings news and commentary, Healthcare stocks news, , Read more ...

CORV - Correvio Reports Third Quarter 2019 Financial Results

NASDAQ: CORV  TSX: CORV FDA Accepts Brinavess™ New Drug Application Advisory Committee Date Set for December 10, 2019 PDUFA Date Set for December 24, 2019 Management to Host Conference Call and Webcast Today, November 14, 2019 at 8:30 a.m. Eastern ( ...

CORV - Correvio to Report Third Quarter 2019 Financial Results

Correvio to Report Third Quarter 2019 Financial Results Canada NewsWire VANCOUVER, Nov. 7, 2019 NASDAQ: CORV  TSX: CORV Conference Call Scheduled for Thursday, November 14, 2019 at 8:30 a.m. Eastern ( 5:30 a.m. Pacific) VANCOUVER , Nov. 7, 2019 /CNW/ - ...
Previous 10 Next 10